ReP USP - Resultado da busca

Artigo de periodico
HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents (2024)
Waitman, Karoline de Barros ; Almeida, Larissa Costa de ; Primi, Marina Candido ; Carlos, Jorge Antonio Elias Godoy ; Ruiz, Claudia; Kronenberger, Thales ; Laufer, Stefan; Goettert, Marcia Ines; Poso, Antti ; Vassiliades, Sandra Valeria ; Souza, Vinicius Albuquerque Moreira de ; Toledo, Mônica Franco Zannini Junqueira ; Hassimotto, Neuza Mariko Aymoto ; Cameron, Michael D; Bannister, Thomas D; Lotufo, Leticia Veras Costa ; Machado Neto, João Agostinho ; Tavares, Maurício T.; Parise Filho, Roberto
Source: European Journal of Medicinal Chemistry. Unidades: FCF, ICB
Subjects: ANTINEOPLÁSICOS, HIBRIDIZAÇÃO, CÉLULAS CULTIVADAS DE TUMOR, PROTEÍNAS, PURINAS, CITOTOXINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WAITMAN, Karoline de Barros et al. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents. European Journal of Medicinal Chemistry, v. 263, p. 1-18 art. 115935, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.ejmech.2023.115935. Acesso em: 05 jun. 2024.
APA
Waitman, K. de B., Almeida, L. C. de, Primi, M. C., Carlos, J. A. E. G., Ruiz, C., Kronenberger, T., et al. (2024). HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents. European Journal of Medicinal Chemistry, 263, 1-18 art. 115935. doi:10.1016/j.ejmech.2023.115935
NLM
Waitman K de B, Almeida LC de, Primi MC, Carlos JAEG, Ruiz C, Kronenberger T, Laufer S, Goettert MI, Poso A, Vassiliades SV, Souza VAM de, Toledo MFZJ, Hassimotto NMA, Cameron MD, Bannister TD, Lotufo LVC, Machado Neto JA, Tavares MT, Parise Filho R. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents [Internet]. European Journal of Medicinal Chemistry. 2024 ; 263 1-18 art. 115935.[citado 2024 jun. 05 ] Available from: https://dx.doi.org/10.1016/j.ejmech.2023.115935
Vancouver
Waitman K de B, Almeida LC de, Primi MC, Carlos JAEG, Ruiz C, Kronenberger T, Laufer S, Goettert MI, Poso A, Vassiliades SV, Souza VAM de, Toledo MFZJ, Hassimotto NMA, Cameron MD, Bannister TD, Lotufo LVC, Machado Neto JA, Tavares MT, Parise Filho R. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents [Internet]. European Journal of Medicinal Chemistry. 2024 ; 263 1-18 art. 115935.[citado 2024 jun. 05 ] Available from: https://dx.doi.org/10.1016/j.ejmech.2023.115935
Artigo de periodico
Unveiling the optimal path: high-pressure homogenization and D-phase emulsification methods for borage oil nanoemulsion design (2024)
Masiero, Jéssica Fagionato; Knirsch, Marcos Camargo ; Barreto, Thayná Lopes ; Arantes, Geraldo José; Stephano, Marco Antônio ; Ishida, Kelly ; Löbenberg, Raimar ; Bou-Chacra, Nadia Araci
Source: Industrial Crops and Products. Unidades: FCF, ICB
Subjects: NANOPARTÍCULAS, DERMATITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASIERO, Jéssica Fagionato et al. Unveiling the optimal path: high-pressure homogenization and D-phase emulsification methods for borage oil nanoemulsion design. Industrial Crops and Products, v. 208, p. 1-10 art. 117853, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.indcrop.2023.117853. Acesso em: 05 jun. 2024.
APA
Masiero, J. F., Knirsch, M. C., Barreto, T. L., Arantes, G. J., Stephano, M. A., Ishida, K., et al. (2024). Unveiling the optimal path: high-pressure homogenization and D-phase emulsification methods for borage oil nanoemulsion design. Industrial Crops and Products, 208, 1-10 art. 117853. doi:10.1016/j.indcrop.2023.117853
NLM
Masiero JF, Knirsch MC, Barreto TL, Arantes GJ, Stephano MA, Ishida K, Löbenberg R, Bou-Chacra NA. Unveiling the optimal path: high-pressure homogenization and D-phase emulsification methods for borage oil nanoemulsion design [Internet]. Industrial Crops and Products. 2024 ; 208 1-10 art. 117853.[citado 2024 jun. 05 ] Available from: https://dx.doi.org/10.1016/j.indcrop.2023.117853
Vancouver
Masiero JF, Knirsch MC, Barreto TL, Arantes GJ, Stephano MA, Ishida K, Löbenberg R, Bou-Chacra NA. Unveiling the optimal path: high-pressure homogenization and D-phase emulsification methods for borage oil nanoemulsion design [Internet]. Industrial Crops and Products. 2024 ; 208 1-10 art. 117853.[citado 2024 jun. 05 ] Available from: https://dx.doi.org/10.1016/j.indcrop.2023.117853
Artigo de periodico
Toward inclusive health care: pharmacists’ perceptions on academic preparedness and health care provision for the LGBTQIA+ community (2024)
Faustino, Vinicius Lima ; Visacri, Marilia Berlofa ; Aguiar, Patrícia Melo
Source: Journal of the American Pharmacists Association. Unidades: FCF, ICB
Subjects: ASSISTÊNCIA À SAÚDE, DIVERSIDADE SEXUAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAUSTINO, Vinicius Lima e VISACRI, Marilia Berlofa e AGUIAR, Patrícia Melo. Toward inclusive health care: pharmacists’ perceptions on academic preparedness and health care provision for the LGBTQIA+ community. Journal of the American Pharmacists Association, v. 64, n. 3, p. 1-3 art. 102066, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.japh.2024.102066. Acesso em: 05 jun. 2024.
APA
Faustino, V. L., Visacri, M. B., & Aguiar, P. M. (2024). Toward inclusive health care: pharmacists’ perceptions on academic preparedness and health care provision for the LGBTQIA+ community. Journal of the American Pharmacists Association, 64( 3), 1-3 art. 102066. doi:10.1016/j.japh.2024.102066
NLM
Faustino VL, Visacri MB, Aguiar PM. Toward inclusive health care: pharmacists’ perceptions on academic preparedness and health care provision for the LGBTQIA+ community [Internet]. Journal of the American Pharmacists Association. 2024 ; 64( 3): 1-3 art. 102066.[citado 2024 jun. 05 ] Available from: https://dx.doi.org/10.1016/j.japh.2024.102066
Vancouver
Faustino VL, Visacri MB, Aguiar PM. Toward inclusive health care: pharmacists’ perceptions on academic preparedness and health care provision for the LGBTQIA+ community [Internet]. Journal of the American Pharmacists Association. 2024 ; 64( 3): 1-3 art. 102066.[citado 2024 jun. 05 ] Available from: https://dx.doi.org/10.1016/j.japh.2024.102066
Artigo de periodico
Organoselenium has a potent fungicidal effect on Cryptococcus neoformans and inhibits the virulence factors (2023)
Jesus, Daniel Felipe Freitas de ; Freitas, Aline Luiza Duarte de; Oliveira, Isadora Maria de ; Almeida, Larissa Costa de ; Bastos, Rafael Wesley; Spadari, Cristina de Castro ; Melo, Analy Salles de Azevedo ; Santos, Daniel de Assis ; Reis, Flavia C. G; Rodrigues, Márcio Lourenço ; Lotufo, Leticia Veras Costa ; Stefani, Hélio Alexandre ; Ishida, Kelly
Source: Antimicrobial Agents and Chemotherapy. Unidades: ICB, FCF, BIOTECNOLOGIA, IQ
Subjects: ANTIFÚNGICOS, FUNGICIDAS, CRYPTOCOCCUS NEOFORMANS, VIRULÊNCIA, FUNGOS MITOSPORICOS, FUNGICIDAS INDUSTRIAIS, TRAÇAS, MICOSES, MICROBIOLOGIA, FARMACOLOGIA, LARVA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JESUS, Daniel Felipe Freitas de et al. Organoselenium has a potent fungicidal effect on Cryptococcus neoformans and inhibits the virulence factors. Antimicrobial Agents and Chemotherapy, v. 67, n. 3, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.1128/aac.00759-22. Acesso em: 05 jun. 2024.
APA
Jesus, D. F. F. de, Freitas, A. L. D. de, Oliveira, I. M. de, Almeida, L. C. de, Bastos, R. W., Spadari, C. de C., et al. (2023). Organoselenium has a potent fungicidal effect on Cryptococcus neoformans and inhibits the virulence factors. Antimicrobial Agents and Chemotherapy, 67( 3), 1-16. doi:10.1128/aac.00759-22
NLM
Jesus DFF de, Freitas ALD de, Oliveira IM de, Almeida LC de, Bastos RW, Spadari C de C, Melo AS de A, Santos D de A, Reis FCG, Rodrigues ML, Lotufo LVC, Stefani HA, Ishida K. Organoselenium has a potent fungicidal effect on Cryptococcus neoformans and inhibits the virulence factors [Internet]. Antimicrobial Agents and Chemotherapy. 2023 ; 67( 3): 1-16.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1128/aac.00759-22
Vancouver
Jesus DFF de, Freitas ALD de, Oliveira IM de, Almeida LC de, Bastos RW, Spadari C de C, Melo AS de A, Santos D de A, Reis FCG, Rodrigues ML, Lotufo LVC, Stefani HA, Ishida K. Organoselenium has a potent fungicidal effect on Cryptococcus neoformans and inhibits the virulence factors [Internet]. Antimicrobial Agents and Chemotherapy. 2023 ; 67( 3): 1-16.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1128/aac.00759-22
Artigo de periodico
1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors (2023)
Tavares, Maurício Temotheo ; Krüger, Arne ; Yan, Sun Liu Rei ; Waitman, Karoline de Barros ; Gomes, Vinícius de Morais ; Oliveira, Daffiny Sumam de ; Paz, Franciarli ; Hilscher, Sebastian ; Schutkowski, Mike ; Sippl, Wolfgang ; Ruiz, Claudia; Toledo, Mônica Franco Zannini Junqueira ; Poso, Antti ; Cameron, Michael D. ; Bannister, Thomas D. ; Kronenberger, Thales ; Parise Filho, Roberto ; Hassimotto, Neuza Mariko Aymoto ; Machado Neto, João Agostinho ; Palmisano, Giuseppe ; Wrenger, Carsten
Source: Scientific Reports. Unidades: FCF, ICB
Subjects: FARMACOLOGIA, PARASITOLOGIA, ANTIMALÁRICOS, EPIGÊNESE GENÉTICA, ÁCIDO FÓLICO, ANTAGONISTAS, PROTEÍNAS, PROTEÍNAS RECOMBINANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Maurício Temotheo et al. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors. Scientific Reports, v. 13, n. 1, p. 20 , 2023Tradução . . Disponível em: https://doi.org/10.1038/s41598-023-47959-z. Acesso em: 05 jun. 2024.
APA
Tavares, M. T., Krüger, A., Yan, S. L. R., Waitman, K. de B., Gomes, V. de M., Oliveira, D. S. de, et al. (2023). 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors. Scientific Reports, 13( 1), 20 . doi:10.1038/s41598-023-47959-z
NLM
Tavares MT, Krüger A, Yan SLR, Waitman K de B, Gomes V de M, Oliveira DS de, Paz F, Hilscher S, Schutkowski M, Sippl W, Ruiz C, Toledo MFZJ, Poso A, Cameron MD, Bannister TD, Kronenberger T, Parise Filho R, Hassimotto NMA, Machado Neto JA, Palmisano G, Wrenger C. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors [Internet]. Scientific Reports. 2023 ; 13( 1): 20 .[citado 2024 jun. 05 ] Available from: https://doi.org/10.1038/s41598-023-47959-z
Vancouver
Tavares MT, Krüger A, Yan SLR, Waitman K de B, Gomes V de M, Oliveira DS de, Paz F, Hilscher S, Schutkowski M, Sippl W, Ruiz C, Toledo MFZJ, Poso A, Cameron MD, Bannister TD, Kronenberger T, Parise Filho R, Hassimotto NMA, Machado Neto JA, Palmisano G, Wrenger C. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors [Internet]. Scientific Reports. 2023 ; 13( 1): 20 .[citado 2024 jun. 05 ] Available from: https://doi.org/10.1038/s41598-023-47959-z
Trabalho de evento-resumo
Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models (2023)
Carlos, Jorge Antonio Elias Godoy ; Almeida, Larissa Costa de ; Lima, Keli; Tavares, Maurício Temotheo ; Waitman, Karoline de Barros ; Lotufo, Leticia Veras Costa ; Parise Filho, Roberto ; Machado Neto, João Agostinho
Source: Anais. Conference titles: Reunião Anual da Sociedade Brasileira de Química/RASBQ. Unidades: ICB, FCF
Assunto: LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARLOS, Jorge Antonio Elias Godoy et al. Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models. 2023, Anais.. São Paulo: Sociedade Brasileira de Química/SBQ, 2023. Disponível em: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf. Acesso em: 05 jun. 2024.
APA
Carlos, J. A. E. G., Almeida, L. C. de, Lima, K., Tavares, M. T., Waitman, K. de B., Lotufo, L. V. C., et al. (2023). Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models. In Anais. São Paulo: Sociedade Brasileira de Química/SBQ. Recuperado de https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
NLM
Carlos JAEG, Almeida LC de, Lima K, Tavares MT, Waitman K de B, Lotufo LVC, Parise Filho R, Machado Neto JA. Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models [Internet]. Anais. 2023 ;[citado 2024 jun. 05 ] Available from: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
Vancouver
Carlos JAEG, Almeida LC de, Lima K, Tavares MT, Waitman K de B, Lotufo LVC, Parise Filho R, Machado Neto JA. Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models [Internet]. Anais. 2023 ;[citado 2024 jun. 05 ] Available from: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
Trabalho de evento-resumo
Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment (2023)
Waitman, Karoline de Barros ; Tavares, Maurício Temotheo ; Almeida, Larissa Costa de ; Carlos, Jorge Antonio Elias Godoy ; Kronenberger, Thales ; Toledo, Mônica Franco Zannini Junqueira ; Lotufo, Leticia Veras Costa ; Machado Neto, João Agostinho ; Parise Filho, Roberto
Source: Anais. Conference titles: Reunião Anual da Sociedade Brasileira de Química/RASBQ. Unidades: FCF, ICB
Subjects: NEOPLASIAS, HIBRIDIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WAITMAN, Karoline de Barros et al. Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment. 2023, Anais.. São Paulo: Sociedade Brasileira de Química/SBQ, 2023. Disponível em: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf. Acesso em: 05 jun. 2024.
APA
Waitman, K. de B., Tavares, M. T., Almeida, L. C. de, Carlos, J. A. E. G., Kronenberger, T., Toledo, M. F. Z. J., et al. (2023). Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment. In Anais. São Paulo: Sociedade Brasileira de Química/SBQ. Recuperado de https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
NLM
Waitman K de B, Tavares MT, Almeida LC de, Carlos JAEG, Kronenberger T, Toledo MFZJ, Lotufo LVC, Machado Neto JA, Parise Filho R. Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment [Internet]. Anais. 2023 ;[citado 2024 jun. 05 ] Available from: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
Vancouver
Waitman K de B, Tavares MT, Almeida LC de, Carlos JAEG, Kronenberger T, Toledo MFZJ, Lotufo LVC, Machado Neto JA, Parise Filho R. Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment [Internet]. Anais. 2023 ;[citado 2024 jun. 05 ] Available from: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
Artigo de periodico
Highly water-soluble dapsone nanocrystals: towards innovative preparations for an undermined drug (2023)
Rocha, Nataly Paredes da ; Souza, Aline de ; Yukuyama, Megumi Nishitani ; Barreto, Thayna Lopes; Macedo, Luiza de Oliveira ; Löbenberg, Raimar ; Araújo, Gabriel Lima Barros de ; Ishida, Kelly ; Bou-Chacra, Nadia Araci
Source: International Journal of Pharmaceutics. Unidades: FCF, ICB
Subjects: MICROBIOLOGIA, ANTI-INFECCIOSOS, ANTIBIÓTICOS, NANOPARTÍCULAS, SOLUBILIDADE, MICROSCOPIA ELETRÔNICA DE VARREDURA, DOENÇAS INFECCIOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Nataly Paredes da et al. Highly water-soluble dapsone nanocrystals: towards innovative preparations for an undermined drug. International Journal of Pharmaceutics, v. 630, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2022.122428. Acesso em: 05 jun. 2024.
APA
Rocha, N. P. da, Souza, A. de, Yukuyama, M. N., Barreto, T. L., Macedo, L. de O., Löbenberg, R., et al. (2023). Highly water-soluble dapsone nanocrystals: towards innovative preparations for an undermined drug. International Journal of Pharmaceutics, 630, 1-12. doi:10.1016/j.ijpharm.2022.122428
NLM
Rocha NP da, Souza A de, Yukuyama MN, Barreto TL, Macedo L de O, Löbenberg R, Araújo GLB de, Ishida K, Bou-Chacra NA. Highly water-soluble dapsone nanocrystals: towards innovative preparations for an undermined drug [Internet]. International Journal of Pharmaceutics. 2023 ; 630 1-12.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122428
Vancouver
Rocha NP da, Souza A de, Yukuyama MN, Barreto TL, Macedo L de O, Löbenberg R, Araújo GLB de, Ishida K, Bou-Chacra NA. Highly water-soluble dapsone nanocrystals: towards innovative preparations for an undermined drug [Internet]. International Journal of Pharmaceutics. 2023 ; 630 1-12.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122428
Trabalho de evento-resumo
Jornada científica dos acadêmicos de farmácia e bioquímica (JCAFB) da FCF-USP: experiência na cidade de Fernão-SP (2017-2020) (2023)
Santos, Luís Carlos Fogaça dos ; Visacri, Marilia Berlofa ; Tavares, José Henrique Pereira Santos ; Cegalla, Natália de Oliveira; Moreira, Lais; Rodrigues, Gabriela Pereira; Passos, Julia Sapienza ; Bueno, Beatriz Lucio; Roth, Gabriel Pascarelli; Schalka, Sofia; Bonin, Beatriz Rossi; Rossi, Magali da Silva Pacheco Nobre ; Mori, Ana Luiza Pereira Moreira; Serpentino, Alice Herminia; Vercelino, Carlos; Costa, João Victor Cabral ; Gruber, Jonas ; Ract, Juliana Neves Rodrigues ; Giarolla, Jeanine ; Epiphanio, Sabrina ; Borelli, Primavera
Source: Anais. Conference titles: Congresso Farmacêutico de São Paulo. Unidades: FCF, IQ, ICMC, ICB
Subjects: FARMÁCIA, BIOQUÍMICA, EVENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Luís Carlos Fogaça dos et al. Jornada científica dos acadêmicos de farmácia e bioquímica (JCAFB) da FCF-USP: experiência na cidade de Fernão-SP (2017-2020). 2023, Anais.. São Paulo: Conselho Regional de Farmácia do Estado de São Paulo/CRFSP, 2023. Disponível em: https://www.crfsp.org.br/documentos/congresso/22_anais_congresso.pdf. Acesso em: 05 jun. 2024.
APA
Santos, L. C. F. dos, Visacri, M. B., Tavares, J. H. P. S., Cegalla, N. de O., Moreira, L., Rodrigues, G. P., et al. (2023). Jornada científica dos acadêmicos de farmácia e bioquímica (JCAFB) da FCF-USP: experiência na cidade de Fernão-SP (2017-2020). In Anais. São Paulo: Conselho Regional de Farmácia do Estado de São Paulo/CRFSP. Recuperado de https://www.crfsp.org.br/documentos/congresso/22_anais_congresso.pdf
NLM
Santos LCF dos, Visacri MB, Tavares JHPS, Cegalla N de O, Moreira L, Rodrigues GP, Passos JS, Bueno BL, Roth GP, Schalka S, Bonin BR, Rossi M da SPN, Mori ALPM, Serpentino AH, Vercelino C, Costa JVC, Gruber J, Ract JNR, Giarolla J, Epiphanio S, Borelli P. Jornada científica dos acadêmicos de farmácia e bioquímica (JCAFB) da FCF-USP: experiência na cidade de Fernão-SP (2017-2020) [Internet]. Anais. 2023 ;[citado 2024 jun. 05 ] Available from: https://www.crfsp.org.br/documentos/congresso/22_anais_congresso.pdf
Vancouver
Santos LCF dos, Visacri MB, Tavares JHPS, Cegalla N de O, Moreira L, Rodrigues GP, Passos JS, Bueno BL, Roth GP, Schalka S, Bonin BR, Rossi M da SPN, Mori ALPM, Serpentino AH, Vercelino C, Costa JVC, Gruber J, Ract JNR, Giarolla J, Epiphanio S, Borelli P. Jornada científica dos acadêmicos de farmácia e bioquímica (JCAFB) da FCF-USP: experiência na cidade de Fernão-SP (2017-2020) [Internet]. Anais. 2023 ;[citado 2024 jun. 05 ] Available from: https://www.crfsp.org.br/documentos/congresso/22_anais_congresso.pdf
Artigo de periodico
Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years (2023)
Vassiliades, Sandra Valeria ; Navarausckas, Vitor Bastos; Dias, Marcio Vinicius Bertacine ; Parise Filho, Roberto
Source: Biointerface Research in Applied Chemistry. Unidades: ICB, FCF
Subjects: TUBERCULOSE, FÁRMACOS, MYCOBACTERIUM TUBERCULOSIS, MICROBIOLOGIA, ANTIBIÓTICOS, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VASSILIADES, Sandra Valeria et al. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years. Biointerface Research in Applied Chemistry, v. 13, n. 1 p. 1-20 art. 79, 2023Tradução . . Disponível em: https://doi.org/10.33263/BRIAC131.079. Acesso em: 05 jun. 2024.
APA
Vassiliades, S. V., Navarausckas, V. B., Dias, M. V. B., & Parise Filho, R. (2023). Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years. Biointerface Research in Applied Chemistry, 13( 1 p. 1-20 art. 79). doi:10.33263/BRIAC131.079
NLM
Vassiliades SV, Navarausckas VB, Dias MVB, Parise Filho R. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years [Internet]. Biointerface Research in Applied Chemistry. 2023 ; 13( 1 p. 1-20 art. 79):[citado 2024 jun. 05 ] Available from: https://doi.org/10.33263/BRIAC131.079
Vancouver
Vassiliades SV, Navarausckas VB, Dias MVB, Parise Filho R. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years [Internet]. Biointerface Research in Applied Chemistry. 2023 ; 13( 1 p. 1-20 art. 79):[citado 2024 jun. 05 ] Available from: https://doi.org/10.33263/BRIAC131.079
Trabalho de evento-resumo
Design of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment (2022)
Waitman, Karoline de Barros ; Tavares, Maurício Temotheo ; Almeida, Larissa Costa de ; Toledo, Mônica Franco Zannini Junqueira ; Machado Neto, João Agostinho ; Lotufo, Leticia Veras Costa ; Parise Filho, Roberto
Source: Anais. Conference titles: Reunião Anual da Sociedade Brasileira de Química. Unidades: FCF, ICB
Subjects: NEOPLASIAS, PURINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WAITMAN, Karoline de Barros et al. Design of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment. 2022, Anais.. São Paulo: Sociedade Brasileira de Química/SBQ, 2022. Disponível em: http://www.sbq.org.br/45ra/anexos/45RASBQ_resumos.pdf. Acesso em: 05 jun. 2024.
APA
Waitman, K. de B., Tavares, M. T., Almeida, L. C. de, Toledo, M. F. Z. J., Machado Neto, J. A., Lotufo, L. V. C., & Parise Filho, R. (2022). Design of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment. In Anais. São Paulo: Sociedade Brasileira de Química/SBQ. Recuperado de http://www.sbq.org.br/45ra/anexos/45RASBQ_resumos.pdf
NLM
Waitman K de B, Tavares MT, Almeida LC de, Toledo MFZJ, Machado Neto JA, Lotufo LVC, Parise Filho R. Design of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment [Internet]. Anais. 2022 ;[citado 2024 jun. 05 ] Available from: http://www.sbq.org.br/45ra/anexos/45RASBQ_resumos.pdf
Vancouver
Waitman K de B, Tavares MT, Almeida LC de, Toledo MFZJ, Machado Neto JA, Lotufo LVC, Parise Filho R. Design of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment [Internet]. Anais. 2022 ;[citado 2024 jun. 05 ] Available from: http://www.sbq.org.br/45ra/anexos/45RASBQ_resumos.pdf
Artigo de periodico
Besifloxacin nanocrystal: towards an innovative ophthalmic preparation (2022)
Jesus, José Izo Santana da Silva de ; Lourenço, Felipe Rebello ; Ishida, Kelly ; Barreto, Thayná Lopes ; Avino, Valdir Carlos ; Santos Neto, Edson dos; Bou-Chacra, Nadia Araci
Source: Pharmaceutics. Unidades: FCF, ICB
Subjects: INFECÇÕES OCULARES, ANTIBIÓTICOS, CONJUNTIVITE VIRAL, NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JESUS, José Izo Santana da Silva de et al. Besifloxacin nanocrystal: towards an innovative ophthalmic preparation. Pharmaceutics, v. 14, p. 1-21 art. 2221, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14102221. Acesso em: 05 jun. 2024.
APA
Jesus, J. I. S. da S. de, Lourenço, F. R., Ishida, K., Barreto, T. L., Avino, V. C., Santos Neto, E. dos, & Bou-Chacra, N. A. (2022). Besifloxacin nanocrystal: towards an innovative ophthalmic preparation. Pharmaceutics, 14, 1-21 art. 2221. doi:10.3390/pharmaceutics14102221
NLM
Jesus JIS da S de, Lourenço FR, Ishida K, Barreto TL, Avino VC, Santos Neto E dos, Bou-Chacra NA. Besifloxacin nanocrystal: towards an innovative ophthalmic preparation [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 2221.[citado 2024 jun. 05 ] Available from: https://doi.org/10.3390/pharmaceutics14102221
Vancouver
Jesus JIS da S de, Lourenço FR, Ishida K, Barreto TL, Avino VC, Santos Neto E dos, Bou-Chacra NA. Besifloxacin nanocrystal: towards an innovative ophthalmic preparation [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 2221.[citado 2024 jun. 05 ] Available from: https://doi.org/10.3390/pharmaceutics14102221
Trabalho de evento-resumo periodico
A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells (2022)
Jaeg, Carlos; Almeida, LC; Lima, K; Tavares, M. T; Waitman, K. B; Lotufo, Leticia Veras Costa ; Parise Filho, Roberto ; Machado Neto, João Agostinho
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HEMO). Unidades: ICB, FCF
Subjects: INIBIDORES DE ENZIMAS, APOPTOSE, LEUCEMIA MIELOIDE AGUDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JAEG, Carlos et al. A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2022.09.267. Acesso em: 05 jun. 2024. , 2022
APA
Jaeg, C., Almeida, L. C., Lima, K., Tavares, M. T., Waitman, K. B., Lotufo, L. V. C., et al. (2022). A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.htct.2022.09.267
NLM
Jaeg C, Almeida LC, Lima K, Tavares MT, Waitman KB, Lotufo LVC, Parise Filho R, Machado Neto JA. A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s158-s159.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1016/j.htct.2022.09.267
Vancouver
Jaeg C, Almeida LC, Lima K, Tavares MT, Waitman KB, Lotufo LVC, Parise Filho R, Machado Neto JA. A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s158-s159.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1016/j.htct.2022.09.267
Artigo de periodico
Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention (2021)
Apolinário, Alexsandra Conceição ; Hauschke, Leon; Nunes, Jessica Ribeiro ; Lourenço, Felipe Rebello ; Lopes, Luciana Biagini
Source: Colloids and Surfaces A. Unidades: FCF, ICB
Subjects: NEOPLASIAS MAMÁRIAS, QUIMIOTERAPIA, QUIMIOTERÁPICOS, SOLUBILIDADE, FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, CITOTOXINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
APOLINÁRIO, Alexsandra Conceição et al. Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention. Colloids and Surfaces A, v. 623, n. 20, p. 1-14 art. 126745, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfa.2021.126745. Acesso em: 05 jun. 2024.
APA
Apolinário, A. C., Hauschke, L., Nunes, J. R., Lourenço, F. R., & Lopes, L. B. (2021). Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention. Colloids and Surfaces A, 623( 20), 1-14 art. 126745. doi:10.1016/j.colsurfa.2021.126745
NLM
Apolinário AC, Hauschke L, Nunes JR, Lourenço FR, Lopes LB. Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention [Internet]. Colloids and Surfaces A. 2021 ; 623( 20): 1-14 art. 126745.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1016/j.colsurfa.2021.126745
Vancouver
Apolinário AC, Hauschke L, Nunes JR, Lourenço FR, Lopes LB. Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention [Internet]. Colloids and Surfaces A. 2021 ; 623( 20): 1-14 art. 126745.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1016/j.colsurfa.2021.126745
Artigo de periodico
Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors (2021)
Tavares, Maurício Temotheo ; Almeida, Larissa Costa de ; Kronenberger, Thales ; Ferreira, Glaucio Monteiro ; Divitiis, Thainá Fujii de ; Toledo, Mônica Franco Zannini Junqueira ; Hassimotto, Neuza Mariko Aymoto ; Machado Neto, João Agostinho ; Lotufo, Leticia Veras Costa ; Parise Filho, Roberto
Source: Bioorganic and Medicinal Chemistry. Unidades: FCF, ICB, PRÓ-G
Subjects: CITOTOXICIDADE IMUNOLÓGICA, ENZIMAS, FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, APOPTOSE, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Maurício Temotheo et al. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors. Bioorganic and Medicinal Chemistry, v. 35, p. 1-42 art. 116085, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2021.116085. Acesso em: 05 jun. 2024.
APA
Tavares, M. T., Almeida, L. C. de, Kronenberger, T., Ferreira, G. M., Divitiis, T. F. de, Toledo, M. F. Z. J., et al. (2021). Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors. Bioorganic and Medicinal Chemistry, 35, 1-42 art. 116085. doi:10.1016/j.bmc.2021.116085
NLM
Tavares MT, Almeida LC de, Kronenberger T, Ferreira GM, Divitiis TF de, Toledo MFZJ, Hassimotto NMA, Machado Neto JA, Lotufo LVC, Parise Filho R. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors [Internet]. Bioorganic and Medicinal Chemistry. 2021 ; 35 1-42 art. 116085.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1016/j.bmc.2021.116085
Vancouver
Tavares MT, Almeida LC de, Kronenberger T, Ferreira GM, Divitiis TF de, Toledo MFZJ, Hassimotto NMA, Machado Neto JA, Lotufo LVC, Parise Filho R. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors [Internet]. Bioorganic and Medicinal Chemistry. 2021 ; 35 1-42 art. 116085.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1016/j.bmc.2021.116085
Artigo de periodico
Nanostructured lipid carriers containing chitosan or sodium alginate for co-encapsulation of antioxidants and an antimicrobial agent for potential application in wound healing (2021)
Fernandez, Sandra Costa; Mattos, Jenyffer K. R; Scheunemann, Gaby Soares ; Salata, Giovanna Cassone ; Chorilli, Marlus ; Watanabe, Ii-sei ; Araujo, Gabriel Lima Barros de ; Santos, Marinilce Fagundes dos ; Ishida, Kelly ; Lopes, Luciana Biagini
Source: International Journal of Biological Macromolecules. Unidades: ICB, FCF
Subjects: ANTIOXIDANTES, LIPÍDEOS, ANATOMIA, BIOLOGIA CELULAR, MICROBIOLOGIA, QUITOSANA, CICATRIZAÇÃO, FERIMENTOS E LESÕES, MATERIAIS NANOESTRUTURADOS, ÓLEOS VEGETAIS, PLANTAS OLEAGINOSAS, FIBROBLASTOS, FOLHAS (PLANTAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDEZ, Sandra Costa et al. Nanostructured lipid carriers containing chitosan or sodium alginate for co-encapsulation of antioxidants and an antimicrobial agent for potential application in wound healing. International Journal of Biological Macromolecules, v. 183, p. 668-680, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ijbiomac.2021.04.168. Acesso em: 05 jun. 2024.
APA
Fernandez, S. C., Mattos, J. K. R., Scheunemann, G. S., Salata, G. C., Chorilli, M., Watanabe, I. -sei, et al. (2021). Nanostructured lipid carriers containing chitosan or sodium alginate for co-encapsulation of antioxidants and an antimicrobial agent for potential application in wound healing. International Journal of Biological Macromolecules, 183, 668-680. doi:10.1016/j.ijbiomac.2021.04.168
NLM
Fernandez SC, Mattos JKR, Scheunemann GS, Salata GC, Chorilli M, Watanabe I-sei, Araujo GLB de, Santos MF dos, Ishida K, Lopes LB. Nanostructured lipid carriers containing chitosan or sodium alginate for co-encapsulation of antioxidants and an antimicrobial agent for potential application in wound healing [Internet]. International Journal of Biological Macromolecules. 2021 ; 183 668-680.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1016/j.ijbiomac.2021.04.168
Vancouver
Fernandez SC, Mattos JKR, Scheunemann GS, Salata GC, Chorilli M, Watanabe I-sei, Araujo GLB de, Santos MF dos, Ishida K, Lopes LB. Nanostructured lipid carriers containing chitosan or sodium alginate for co-encapsulation of antioxidants and an antimicrobial agent for potential application in wound healing [Internet]. International Journal of Biological Macromolecules. 2021 ; 183 668-680.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1016/j.ijbiomac.2021.04.168
Artigo de periodico
Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in Cryptococcosis (2021)
Yukuyama, Megumi Nishitani ; Ishida, Kelly ; Araujo, Gabriel Lima Barros de ; Spadari, Cristina de Castro ; Souza, Aline de ; Löbenberg, Raimar ; Henostroza, Mirla Anali Bazan; Folchini, Beatriz Rabelo; Peroni, Camilla Midori; Peters, Maria Christina Camasmie ; Oliveira, Isabela Fernandes de; Miyagi, Mariana Yasue Saito ; Bou-Chacra, Nadia Araci
Source: Colloids and Surfaces A. Unidades: ICB, FCF
Subjects: MENINGITE, ANTIFÚNGICOS, PLANEJAMENTO DE FÁRMACOS, CRIPTOCOCOSE, EMULSÕES (FORMAS FARMACÊUTICAS), CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YUKUYAMA, Megumi Nishitani et al. Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in Cryptococcosis. Colloids and Surfaces A, v. 630, p. 1-10 art. 127631, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfa.2021.127631. Acesso em: 05 jun. 2024.
APA
Yukuyama, M. N., Ishida, K., Araujo, G. L. B. de, Spadari, C. de C., Souza, A. de, Löbenberg, R., et al. (2021). Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in Cryptococcosis. Colloids and Surfaces A, 630, 1-10 art. 127631. doi:10.1016/j.colsurfa.2021.127631
NLM
Yukuyama MN, Ishida K, Araujo GLB de, Spadari C de C, Souza A de, Löbenberg R, Henostroza MAB, Folchini BR, Peroni CM, Peters MCC, Oliveira IF de, Miyagi MYS, Bou-Chacra NA. Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in Cryptococcosis [Internet]. Colloids and Surfaces A. 2021 ; 630 1-10 art. 127631.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1016/j.colsurfa.2021.127631
Vancouver
Yukuyama MN, Ishida K, Araujo GLB de, Spadari C de C, Souza A de, Löbenberg R, Henostroza MAB, Folchini BR, Peroni CM, Peters MCC, Oliveira IF de, Miyagi MYS, Bou-Chacra NA. Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in Cryptococcosis [Internet]. Colloids and Surfaces A. 2021 ; 630 1-10 art. 127631.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1016/j.colsurfa.2021.127631
Artigo de periodico
Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole (2020)
Passos, Julia Sapienza ; Martino, Luiza Capello de; Dartora, Vanessa Franco Carvalho; Araujo, Gabriel Lima Barros de ; Ishida, Kelly ; Lopes, Luciana Biagini
Source: European Journal of Pharmaceutical Sciences. Unidades: FCF, ICB
Subjects: MICROBIOLOGIA, FARMACOLOGIA, NANOPARTÍCULAS, ANTIFÚNGICOS, PELE, ESPOROTRICOSE, DERMATOPATIAS INFECCIOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASSOS, Julia Sapienza et al. Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole. European Journal of Pharmaceutical Sciences, v. 149, p. 11 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2020.105296. Acesso em: 05 jun. 2024.
APA
Passos, J. S., Martino, L. C. de, Dartora, V. F. C., Araujo, G. L. B. de, Ishida, K., & Lopes, L. B. (2020). Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole. European Journal of Pharmaceutical Sciences, 149, 11 . doi:10.1016/j.ejps.2020.105296
NLM
Passos JS, Martino LC de, Dartora VFC, Araujo GLB de, Ishida K, Lopes LB. Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 149 11 .[citado 2024 jun. 05 ] Available from: https://doi.org/10.1016/j.ejps.2020.105296
Vancouver
Passos JS, Martino LC de, Dartora VFC, Araujo GLB de, Ishida K, Lopes LB. Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 149 11 .[citado 2024 jun. 05 ] Available from: https://doi.org/10.1016/j.ejps.2020.105296
Artigo de periodico
Novel 2-Aryloxazoline compounds exhibit an inhibitory effect on Candida spp., including antifungal-resistant isolates (2020)
Argomedo, Luis Miguel Zaravia; Barroso, Vinicius de Morais; Barreiro, Cristiane de Souza; Rocha, Mariana Pompilio Darbem ; Ishida, Kelly ; Stefani, Hélio Alexandre
Source: ACS Medicinal Chemistry Letters. Unidades: ICB, FCF
Subjects: MICROBIOLOGIA, ANTIFÚNGICOS, MICOLOGIA MÉDICA, CANDIDA, ASPERGILLUS, CITOTOXINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARGOMEDO, Luis Miguel Zaravia et al. Novel 2-Aryloxazoline compounds exhibit an inhibitory effect on Candida spp., including antifungal-resistant isolates. ACS Medicinal Chemistry Letters, v. 11, n. 12, p. 2470–2475, 2020Tradução . . Disponível em: https://doi.org/10.1021/acsmedchemlett.0c00449. Acesso em: 05 jun. 2024.
APA
Argomedo, L. M. Z., Barroso, V. de M., Barreiro, C. de S., Rocha, M. P. D., Ishida, K., & Stefani, H. A. (2020). Novel 2-Aryloxazoline compounds exhibit an inhibitory effect on Candida spp., including antifungal-resistant isolates. ACS Medicinal Chemistry Letters, 11( 12), 2470–2475. doi:10.1021/acsmedchemlett.0c00449
NLM
Argomedo LMZ, Barroso V de M, Barreiro C de S, Rocha MPD, Ishida K, Stefani HA. Novel 2-Aryloxazoline compounds exhibit an inhibitory effect on Candida spp., including antifungal-resistant isolates [Internet]. ACS Medicinal Chemistry Letters. 2020 ; 11( 12): 2470–2475.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1021/acsmedchemlett.0c00449
Vancouver
Argomedo LMZ, Barroso V de M, Barreiro C de S, Rocha MPD, Ishida K, Stefani HA. Novel 2-Aryloxazoline compounds exhibit an inhibitory effect on Candida spp., including antifungal-resistant isolates [Internet]. ACS Medicinal Chemistry Letters. 2020 ; 11( 12): 2470–2475.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1021/acsmedchemlett.0c00449
Artigo de periodico
Using a fragment-based approach to identify alternative chemical scaffolds targeting dihydrofolate reductase from Mycobacterium tuberculosis (2020)
Ribeiro, João A.; Hammer, Alexander ; Zuniga, Gerardo A. Libreros ; Pacheco, Sair Maximo Chavez ; Tyrakis, Petros ; Oliveira, Gabriel S. de; Kirkman, Timothy ; Bakali, Jamal El ; Rocco, Silvana A. ; Sforça, Mauricio L. ; Parise Filho, Roberto ; Coyne, Anthony G. ; Blundell, Tom L. ; Abell, Chris ; Dias, Marcio Vinicius Bertacine
Source: ACS Infectious Diseases. Unidades: FCF, ICB
Subjects: MYCOBACTERIUM TUBERCULOSIS, ÁCIDO FÓLICO, MICROBIOLOGIA, INIBIDORES DE ENZIMAS, ATIVAÇÃO ENZIMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, João A. et al. Using a fragment-based approach to identify alternative chemical scaffolds targeting dihydrofolate reductase from Mycobacterium tuberculosis. ACS Infectious Diseases, v. 6, p. 2192−2201 : + Supplementary materials ( S1-S16), 2020Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.0c00263. Acesso em: 05 jun. 2024.
APA
Ribeiro, J. A., Hammer, A., Zuniga, G. A. L., Pacheco, S. M. C., Tyrakis, P., Oliveira, G. S. de, et al. (2020). Using a fragment-based approach to identify alternative chemical scaffolds targeting dihydrofolate reductase from Mycobacterium tuberculosis. ACS Infectious Diseases, 6, 2192−2201 : + Supplementary materials ( S1-S16). doi:10.1021/acsinfecdis.0c00263
NLM
Ribeiro JA, Hammer A, Zuniga GAL, Pacheco SMC, Tyrakis P, Oliveira GS de, Kirkman T, Bakali JE, Rocco SA, Sforça ML, Parise Filho R, Coyne AG, Blundell TL, Abell C, Dias MVB. Using a fragment-based approach to identify alternative chemical scaffolds targeting dihydrofolate reductase from Mycobacterium tuberculosis [Internet]. ACS Infectious Diseases. 2020 ; 6 2192−2201 : + Supplementary materials ( S1-S16).[citado 2024 jun. 05 ] Available from: https://doi.org/10.1021/acsinfecdis.0c00263
Vancouver
Ribeiro JA, Hammer A, Zuniga GAL, Pacheco SMC, Tyrakis P, Oliveira GS de, Kirkman T, Bakali JE, Rocco SA, Sforça ML, Parise Filho R, Coyne AG, Blundell TL, Abell C, Dias MVB. Using a fragment-based approach to identify alternative chemical scaffolds targeting dihydrofolate reductase from Mycobacterium tuberculosis [Internet]. ACS Infectious Diseases. 2020 ; 6 2192−2201 : + Supplementary materials ( S1-S16).[citado 2024 jun. 05 ] Available from: https://doi.org/10.1021/acsinfecdis.0c00263

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration